Sheng‐Yu Jin

881 total citations
39 papers, 703 citations indexed

About

Sheng‐Yu Jin is a scholar working on Immunology, Hematology and Surgery. According to data from OpenAlex, Sheng‐Yu Jin has authored 39 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 11 papers in Hematology and 9 papers in Surgery. Recurrent topics in Sheng‐Yu Jin's work include Complement system in diseases (14 papers), Platelet Disorders and Treatments (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Sheng‐Yu Jin is often cited by papers focused on Complement system in diseases (14 papers), Platelet Disorders and Treatments (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Sheng‐Yu Jin collaborates with scholars based in South Korea, United States and China. Sheng‐Yu Jin's co-authors include X. Long Zheng, Christopher G. Skipwith, Hee Jae Lee, Joo‐Ho Chung, Mee‐Suk Hong, Sung‐Vin Yim, Seung‐Jae Hong, Juan Xiao, Hun‐Kuk Park and Jan Voorberg and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and Advanced Science.

In The Last Decade

Sheng‐Yu Jin

35 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng‐Yu Jin South Korea 15 316 211 157 99 82 39 703
Nora Butta Spain 17 100 0.3× 450 2.1× 280 1.8× 72 0.7× 36 0.4× 85 905
Ioanna Mosialou United States 12 166 0.5× 309 1.5× 552 3.5× 136 1.4× 53 0.6× 17 1.3k
Fatma Sılan Türkiye 15 100 0.3× 92 0.4× 269 1.7× 31 0.3× 97 1.2× 78 759
Xiaohe Cai United States 14 118 0.4× 141 0.7× 356 2.3× 68 0.7× 24 0.3× 24 1000
Friedrich Felix Hoyer Germany 14 274 0.9× 181 0.9× 307 2.0× 113 1.1× 25 0.3× 19 814
Zhanyun Da China 16 261 0.8× 54 0.3× 192 1.2× 129 1.3× 413 5.0× 36 775
Loredana De Pasquale Italy 13 90 0.3× 79 0.4× 272 1.7× 42 0.4× 35 0.4× 35 722
Sara Bonissoni Italy 13 390 1.2× 73 0.3× 291 1.9× 36 0.4× 50 0.6× 17 1.3k
A. Wright United States 13 358 1.1× 128 0.6× 206 1.3× 13 0.1× 176 2.1× 31 909
Nidia Messias United States 13 80 0.3× 97 0.5× 356 2.3× 102 1.0× 67 0.8× 21 809

Countries citing papers authored by Sheng‐Yu Jin

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Yu Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Yu Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Yu Jin more than expected).

Fields of papers citing papers by Sheng‐Yu Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Yu Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Yu Jin. The network helps show where Sheng‐Yu Jin may publish in the future.

Co-authorship network of co-authors of Sheng‐Yu Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Yu Jin. A scholar is included among the top collaborators of Sheng‐Yu Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Yu Jin. Sheng‐Yu Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Mingdong, Sheng‐Yu Jin, Xin Fu, et al.. (2025). Activation of Kir4.1 Channels by 2‐D08 Promotes Myelin Repair in Multiple Sclerosis. Advanced Science. 12(34). e02032–e02032. 1 indexed citations
2.
Cui, Minghua, Quanzhu Chen, Nan Wang, et al.. (2024). Single Nucleotide Polymorphism. PubMed. 12(8). 927–927.
4.
Cao, Yang, Yanan Deng, Junling Liu, et al.. (2022). Defective VWF secretion due to expression ofMYH9-RD E1841K mutant in endothelial cells disrupts hemostasis. Blood Advances. 6(15). 4537–4552. 4 indexed citations
5.
Park, Kyung-Soon, et al.. (2021). Long-term outcomes of cementless femoral stem revision with the Wagner cone prosthesis. Journal of Orthopaedic Surgery and Research. 16(1). 375–375. 9 indexed citations
6.
Li, Hongyan, et al.. (2021). CUDC-101 enhances the chemosensitivity of gemcitabine-treated lymphoma cells. Leukemia Research. 106. 106575–106575. 7 indexed citations
8.
Jin, Sheng‐Yu, et al.. (2020). Survival Analysis of Total Hip Arthroplasty for High Hip Dislocation Secondary to Developmental Dysplasia or Septic Arthritis of the Hip. The Journal of Arthroplasty. 36(5). 1671–1677. 4 indexed citations
9.
Jin, Sheng‐Yu, et al.. (2012). Ectopic Expression of ADAMTS13 in Platelets As a Novel Therapeutic Approach for Arterial Thrombosis. Blood. 120(21). 491–491. 1 indexed citations
10.
Niiya, Masami, Masayuki Endo, Dezhi Shang, et al.. (2008). Correction of ADAMTS13 Deficiency by In Utero Gene Transfer of Lentiviral Vector encoding ADAMTS13 Genes. Molecular Therapy. 17(1). 34–41. 47 indexed citations
11.
Jin, Sheng‐Yu, et al.. (2006). Analysis of the Monocyte Chemoattractant Protein 1 -2518 Promoter Polymorphism in Korean Patients with Alopecia Areata. Journal of Korean Medical Science. 21(1). 90–90. 12 indexed citations
12.
Jin, Sheng‐Yu, Hyun‐Ho Park, Guangzhe Li, et al.. (2004). Association of Angiotensin Converting Enzyme Gene I/D Polymorphism of Vitiligo in Korean Population. Pigment Cell Research. 17(1). 84–86. 43 indexed citations
13.
Lee, Byung-Cheol, Hee Jae Lee, Sheng‐Yu Jin, et al.. (2004). The Inhibitory Effects of Aqueous Extract of Magnolia officinalis on Human Mesangial Cell Proliferation by Regulation of Platelet-Derived Growth Factor-BB and Transforming Growth Factor-β1 Expression. Journal of Pharmacological Sciences. 94(1). 81–85. 10 indexed citations
14.
Kim, Jin Seok, Hee Jae Lee, Hyungwoon Koo, et al.. (2004). Impact of IL-1 receptor antagonist gene polymorphism on schizophrenia and bipolar disorder. Psychiatric Genetics. 14(3). 165–167. 29 indexed citations
15.
Jin, Sheng‐Yu, Hyun‐Ho Park, Guangzhe Li, et al.. (2004). Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients. Journal of Dermatological Science. 35(3). 181–186. 26 indexed citations
16.
Kim, Sung-Do, Jaeman Park, Il‐Soo Kim, et al.. (2004). Association of IL-1?, IL-1ra, and TNF-? gene polymorphisms in childhood nephrotic syndrome. Pediatric Nephrology. 19(3). 295–299. 18 indexed citations
17.
Jin, Sheng‐Yu, Myung‐Chul Yoo, Hee Jae Lee, et al.. (2004). Estrogen receptor-α gene haplotype is associated with primary knee osteoarthritis in Korean population. Arthritis Research & Therapy. 6(5). R415–21. 75 indexed citations
19.
Hong, Mee‐Suk, Sheng‐Yu Jin, Hee Jae Lee, et al.. (2004). Association between polymorphism in intron 1 of cocaine- and amphetamine-regulated transcript gene with alcoholism, but not with bipolar disorder and schizophrenia in Korean population. Neuroscience Letters. 365(1). 54–57. 34 indexed citations
20.
Hong, Seung‐Jae, Hyung-In Yang, Myung Chul Yoo, et al.. (2003). Angiotensin converting enzyme gene polymorphism in Korean patients with primary knee osteoarthritis. Experimental & Molecular Medicine. 35(3). 189–195. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026